2023 - PCP Blog Posts
-
Meeting 1 Recap: Opportunities for Enhancing Patient Navigation
On October 17, 2023, the President’s Cancer Panel convened the first of three public meetings with key experts to discuss gaps and opportunities at the intersection of technology and patient navigation. Read our latest blog post to find out more about common themes and priority areas that emerged from this meeting.
-
Panel Recommendations in Action: Addressing Social Determinants of Health in Cancer Care
A key to addressing health disparities - as highlighted in the 2010 Panel Report - is addressing social determinants of health in patient care. Learn how organizations are taking steps to better address patients’ social needs and risks in cancer care.
-
National Cancer Plan Stakeholder Meeting: Cancer Community Comes Together to Share Ideas for Progress
On September 7th, the Panel convened a meeting with stakeholders from across the cancer community to highlight progress towards the National Cancer Plan’s goals and discuss opportunities for improvement. Check out our latest blog for a meeting recap and learn more about the Panel’s next steps.
-
Panel Recommendations in Action: The National Breast Cancer Roundtable
The National Breast Cancer Roundtable was born out of the call for action by the President's Cancer Panel. Learn more about how the American Cancer Society, the leading force behind the Roundtable, spearheads this effort to improve equity and access in cancer screening.
-
What Is the National Cancer Program?
One of the most important tasks of the President’s Cancer Panel is to monitor the National Cancer Program. Learn more about this critical effort that brings together the cancer community to make progress in reducing the burden of cancer.
-
President's Cancer Panel Commends National Cancer Plan
On April 3, 2023, with leadership from National Cancer Institute (NCI) Director Monica Bertagnolli, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan to guide the nation’s efforts against cancer.